1. Association of Serum Bile Acids Profile and Pathway Dysregulation With the Risk of Developing Diabetes Among Normoglycemic Chinese Adults: Findings From the 4C Study
   Jieli Lu et al, 2021, Diabetes Care CrossRef
2. High-protein high-konjac glucomannan diets changed glucose and lipid metabolism by modulating colonic microflora and bile acid profiles in healthy mouse models
   Yetong Xu et al, 2024, Food & Function CrossRef
3. Evidence for liver energy metabolism programming in offspring subjected to intrauterine undernutrition during midgestation
   Xiaoling Zhou et al, 2019, Nutrition & Metabolism CrossRef
4. New Paradigms for Familiar Diseases: Lessons Learned on Circulatory Bacterial Signatures in Cardiometabolic Diseases
   Rima Chakaroun et al, 2022, Experimental and Clinical Endocrinology & Diabetes CrossRef
5. Chains of evidence from correlations to causal molecules in microbiome-linked diseases
   Snehal N. Chaudhari et al, 2021, Nature Chemical Biology CrossRef
6. The Role of Bile Acids in Cardiovascular Diseases: from Mechanisms to Clinical Implications
   Shuwen Zhang et al, 2022, Aging and disease CrossRef
7. Serum Proteomic Analysis of Cannabis Use Disorder in Male Patients
   Fawaz Alasmari et al, 2021, Molecules CrossRef
8. Chenodeoxycholic Acid Ameliorates AlCl3-Induced Alzheimer’s Disease Neurotoxicity and Cognitive Deterioration via Enhanced Insulin Signaling in Rats
   Firas H. Bazzari et al, 2019, Molecules CrossRef
9. Effects of Resveratrol Supplementation and Exercise on Apoptosis, Lipid Profile, and Expression of Farnesoid X Receptor, Liver X Receptor and Sirtuin 1 Genes in the Liver of Type 1 Diabetic Rats
   Ali Nouri et al, 2022, Medical Laboratory Journal CrossRef
10. Effects of Sleeve Gastrectomy on Nonalcoholic Fatty Liver Disease in an Obese Rat Model
    Kiminori Watanabe et al, 2018, Obesity Surgery CrossRef
11. Linking Nonalcoholic Fatty Liver Disease and Brain Disease: Focusing on Bile Acid Signaling
    Zi-Lin Ren et al, 2022, International Journal of Molecular Sciences CrossRef
12. Ganoderic acid A from Ganoderma lucidum ameliorates lipid metabolism and alters gut microbiota composition in hyperlipidemic mice fed a high-fat diet
    Wei-Ling Guo et al, 2020, Food & Function CrossRef
13. Farnesoid X Receptor Deficiency Induces Hepatic Lipid and Glucose Metabolism Disorder via Regulation of Pyruvate Dehydrogenase Kinase 4
    Wenyi Deng et al, 2022, Oxidative Medicine and Cellular Longevity CrossRef
14. Bile acids at the cross-roads of gut microbiome–host cardiometabolic interactions
    Paul M. Ryan et al, 2017, Diabetology & Metabolic Syndrome CrossRef
15. Gut microbiota: a promising target against cardiometabolic diseases
    Moritz V. Warmbrunn et al, 2020, Expert Review of Endocrinology & Metabolism CrossRef
16. Plant Compounds for the Treatment of Diabetes, a Metabolic Disorder: NF-κB as a Therapeutic Target
    Ravi Sahukari et al, 2020, Current Pharmaceutical Design CrossRef
17. Metabolomics-based evidence of the hypoglycemic effect of Ge-Gen-Jiao-Tai-Wan in type 2 diabetic rats via UHPLC-QTOF/MS analysis
    Wenbo Wang et al, 2018, Journal of Ethnopharmacology CrossRef
18. Mechanistic evaluation of AMPK/SIRT1/FXR signaling axis, inflammation, and redox status in thioacetamide‐induced liver cirrhosis: The role ofCichorium intybuslinn (chicory)‐supplemented diet
    Walaa A. Keshk et al, 2019, Journal of Food Biochemistry CrossRef